At Takeda Australia we focus on 2 therapeutic areas: oncology and gastroenterology.
For more than 25 years, Takeda has focused on improving the lives of patients through the delivery of innovative medicines and dedicated patient disease support programs in gastroenterology (GI). Takeda prioritises areas of GI associated with high unmet need, such as inflammatory bowel disease, GI acid-related diseases and GI motility disorders.
We endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies.
Please visit takedaoncology.com for more information.